ArticleBritish journal of pharmacology2018

The clinically used PARP inhibitor olaparib improves organ function, suppresses inflammatory responses and accelerates wound healing in a murine model of third-degree burn injury.

Akbar Ahmad et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.